IMF’s Nurse Leadership Board Authors ‘Multiple Myeloma’ Supplement in CJON

  • NLB Multiple Myeloma Supplement
    October 02, 2017

    IMF’s Nurse Leadership Board Authors ‘Multiple Myeloma’ Supplement in CJON

rss

The Newsroom

In October 2017, the Clinical Journal of Nursing Oncology published a “Multiple Myeloma” supplement authored by the International Myeloma Foundation’s Nurse Leadership Board. This supplement provides downloadable PDFs of research-based articles on myeloma symptoms and complications and their management. Each article includes an activity for CNE credit. Also included are educational tips sheets for patients and healthcare providers. Read more about these resources below.

Articles Available for Download

Disease and Symptom Care: A Focus on Specific Needs of Patients With Multiple Myeloma

Patients with multiple myeloma cope with short- and long-term side effects of treatment and consequences of the disease itself. This article discusses the many reasons for inadequate management of symptoms, such as patients fearing treatment interruption or the clinician not properly assessing or addressing symptoms.

Distress, Fatigue, and Sexuality: Understanding and Treating Concerns and Symptoms in Patients with Multiple Myeloma

The psychological needs of multiple myeloma patients and their caregivers might be overlooked. As a result, patients may experience distress and suffer compromising outcomes. If these psychological needs are untreated, a multiple myeloma patient’s ability to make decisions and adhere to treatment could be impaired. This article aims to guide oncology nurses to recognize and manage distress, fatigue, and sexual dysfunction in patients with multiple myeloma.

Renal, GI, and Peripheral Nerves: Evidence-Based Recommendations for the Management of Symptoms and Care for Patients With Multiple Myeloma

Many multiple myeloma patients may “experience damage to the kidneys and peripheral nerves at diagnosis or throughout the course of the disease.” They face “symptoms of diarrhea, nausea, vomiting, or constipation.” This article aims “to provide insight into the prevention and management or organ health-related toxicities and give best practice recommendations for optimal nursing care.”

Heart and Lung Complications: Assessment and Prevention of Venous Thromboembolism and Cardiovascular Disease in Patients With Multiple Myeloma

Multiple myeloma patients may experience venous thromboembolism (VTE) and cardiovascular (CV) disease. VTE and CV are separate medical conditions; however, they can both be “serious and life-threatening.” This article describes “the influence of CV disease on patients with multiple myeloma.” It also reviews how to identify and treat these conditions.

Bone Health, Pain, and Mobility: Evidence-Based Recommendations for Patients With Multiple Myeloma

About 85% of multiple myeloma patients develop bone disease. Bone disease is characterized by the presence of lytic bone lesions. In multiple myeloma patients, these lesions may cause “fractures, poor circulation, blood clots, pain, poor mobility, and decreased quality of life.” This article aims to guide nurses “in the assessment and management of bone disease, pain, and mobility in patients with multiple myeloma at varying points in their disease trajectory.”

Myelosuppression, Bone Disease, and Acute Renal Failure: Evidence-Based Recommendations for Oncologic Emergencies

Multiple myeloma and its treatment may lead to potentially life-threatening conditions that require immediate medical attention. These oncological emergencies may include myelosuppression (anemia, neutropenia, and thrombocytopenia), bone-related emergencies, and acute renal failure. This article reviews “the pathophysiology of these multiple myeloma-associated oncology emergencies and provides a framework for assessment and effective intervention.”


Related Links:

10 Steps to Better Care: Step 4: Supportive Care
Video: “Managing Side Effects”
Video: “Managing Bone Disease”


About the Nurse Leadership Board

The International Myeloma Foundation (IMF) Nurse Leadership Board® (NLB) is a professional partnership representing nurse experts from leading medical centers caring for myeloma patients. The NLB’s primary mission is to improve the nursing care and self-care of patients with myeloma by educating nurses and patients via publications, symposia, multimedia, and research.